Vanquish PANDA EUS successfully wrapped up an exciting presence at DDW 2026, where we showcased how AI-supported EUS can elevate image quality, standardize pancreatic imaging, and assist with earlier lesion detection in real-world endoscopy practice.

Below is the updated recap version with your confirmed dates and location integrated.

DDW 2026 | Vanquish PANDA EUS

Vanquish is proud to have participated in Digestive Disease Week (DDW) 2026, held May 2–5, 2026, at McCormick Place Convention Center in Chicago, Illinois. At DDW 2026, we demonstrated how AI-supported synchronous image enhancement supports decision making, and assists with earlier lesion detection across diverse endoscopy practices. Vanquish also supports longitudinal tracking and research studies.

Thank you to the many gastroenterologists, endoscopists, surgeons, researchers, and industry partners who visited our booth, explored the PANDA EUS platform, and shared feedback grounded in their real-world experience with pancreatic imaging.

Event details

Conference: Digestive Disease Week (DDW) 2026
Dates: May 2–5, 2026
Location: McCormick Place Convention Center, Chicago, IL — and online
Hosted by: Vanquish Cancer and the PANDA EUS collaborative research network

Our DDW 2026 activities centered on helping clinicians visualize how AI-supported EUS can integrate into existing workflows without adding complexity.

Clinical focus

At DDW 2026, we highlighted how PANDA EUS can support practicing endosonographers and gastroenterologists in addressing daily challenges in pancreatic imaging.

Earlier recognition of high-risk lesions through AI-supported detection designed to surface subtle, clinically meaningful EUS signals that may be missed under heavy case loads.
Improved image quality and more standardized imaging protocols to support clear visualization of landmarks, lesions, and cysts across different sites and equipment.
Practical integration into existing EUS workflows, including support for longitudinal tracking of tumors and cysts and video-in-the-cloud capabilities to enable multi-site collaboration and research.

What clinicians told us at DDW 2026

Feedback from DDW 2026 attendees reaffirmed key needs that PANDA EUS is built to address.

A strong desire for tools that improve image quality, stabilize landmark recognition, and standardize imaging so findings are comparable across centers and over time.
Interest in real-time lesion detection, better cyst characterization, and support in differentiating inflammatory from malignant disease, especially in complex or borderline cases.
Enthusiasm for video capture and cloud review that can facilitate expert input, referrals between community and academic centers, and structured research without disrupting procedure flow.

Many clinicians also emphasized the importance of user-friendly interfaces and minimal latency, echoing feedback from your DDW Likert survey and reinforcing our focus on making AI support feel like a natural extension of EUS practice.

Why DDW 2026 matters for PANDA EUS

DDW 2026 provided the opportunity to test PANDA EUS with a broad cross-section of endoscopy practices—from high-volume academic centers to private practices and integrated health systems—and to collect real-world insights that will inform the next generation of our models and workflows.

PANDA EUS aims to reduce variability in EUS interpretation, help detect high-risk lesions earlier, and provide more consistent decision support at the point of care.
By combining AI-guided detection with robust video capture and collaborative review, PANDA EUS supports both routine clinical care and multi-site research in pancreatic imaging.
The engagement and ideas shared at DDW 2026 are directly shaping our roadmap, including enhancements in interface design, training workflows, and integration with existing imaging and reporting systems.

Join the PANDA EUS research network

Building on the momentum from DDW 2026, we are expanding our collaborative research network to refine PANDA EUS using real-world EUS videos, images, and clinical data.

We are partnering with gastroenterologists, endoscopists, surgeons, oncologists, and researchers worldwide to design and execute studies on lesion detection, cyst characterization, and standardized imaging.
Participating sites can contribute de-identified EUS content, validate AI outputs against clinical and pathology outcomes, and help define clinically meaningful endpoints.
Many DDW participants expressed interest in research aimed at improving PANDA EUS, including applications in lesion detection, cyst characterization, and differentiation of inflammatory versus malignant disease.

Continue the conversation

We are grateful to everyone who engaged with us at DDW 2026 and helped shape the future of PANDA EUS. If you would like to continue the discussion, explore collaborations, or see a follow-up demonstration tailored to your practice:

DDW 2026 | Vanquish PANDA EUS